Replies to post #699949 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

OncoJock,

Dr. Linda Liau being affiliated is WAY more than enough to fill the void you seem to feel is necessary to fill. Throw in Dr. Keyoumars Ashkan and another Dr who is a patient advocate and you have way more than enough representation.
Now if you looked more closely at failed biotechs you would notice that a significant percentage were run by medical doctors that ran into problems with obtaining sufficient financing to complete the journey to profitability for investors without caving into financial pressure that allowed others to take over on the cheap. ENMD fell to Celgene precisely this way and DNDN wasn’t much different. Many others have fallen this way as well. NWBO, on the other hand, is setting up for a long term leadership role. Best wishes.

[dstock07734]

That's all you picked up from the elite school? How pathetic!

You didn't know Steven Jobs didn't know coding, did you? Things don't add up the way you anticipated, which is a good thing for the true longs.

[ilovetech]

OncoJock - Thanks for doing the math. The last thing I would like is to have a bunch of -

I hold shares in several other biotech companies developing cancer medicine and the best ones have physician-type doctors (in addition to PhD-type doctors) in positions of senior management.

Something doesn't add up.

Business and Doctors are like oil and vinegar. Look at you. You're driven by fear. It takes balls to be like Linda, and that's before we consider aptitude, and multi-dimensional skill sets. Being a nerd doesn't translate to being a leader.

[meirluc]

With no one who has ever treated a patient with GBM on NWBO's staff,
it is all the more remarkable that NWBO is about to receive approval to
market a treatment for GBM patients that is by far better than any of
the treatments that have been available until now.

Oh, and I almost forgot that NWBO has for years been getting help
and advice from several UCLA oncologists including Dr. Linda Liau
who has for some time been on NWBO's Scientific Advisory Board.

And final bottom line: GBM patients will not be treated by oncologists
at NWBO's headquarters in Maryland , USA. Instead, the GBM treatment
(the autologous DCVax-L vaccine), will be manufactured in Sawston, UK
and the patients will be treated by real oncologists in UK hospitals.